Brought to you by 
HGS,SmithKline redefine 1993 diagnostics agreement
Sep 1997
Executive Summary
Human Genome Sciences and SmithKline Beecham have redefined the terms of their 1993 agreement that gave SB the right to develop and sell diagnostic tests based on HGS human gene technology.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
HGS,SmithKline redefine 1993 diagnostics agreement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice